7.19
price up icon3.30%   0.23
after-market 시간 외 거래: 7.15 -0.04 -0.56%
loading

Personalis Inc 주식(PSNL)의 최신 뉴스

pulisher
Mar 18, 2026

Personalis, Inc. (PSNL): A bull case theory - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

229,435 Shares in Personalis, Inc. $PSNL Bought by Oracle Investment Management Inc. - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption - BioSpace

Mar 18, 2026
pulisher
Mar 18, 2026

Personalis promotes Richard Chen to president role By Investing.com - Investing.com South Africa

Mar 18, 2026
pulisher
Mar 17, 2026

Personalis appoints Richard Chen as president and updates compensation package - Investing.com India

Mar 17, 2026
pulisher
Mar 17, 2026

Personalis (PSNL) Appoints Richard Chen as President - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

Personalis (PSNL) CFO granted 206,250 options and 34,375 RSUs - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Personalis (PSNL) grants options and RSUs to Chief Legal Officer - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Personalis (PSNL) CEO receives major stock option and RSU grants - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Personalis (PSNL) awards RSUs and stock options to its CMO - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Investor Mood: Can Personalis Inc grow without external funding2026 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

Personalis (NASDAQ: PSNL) elevates Richard Chen to President - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Personalis, Inc. Announces the Promotion of Richard Chen, M.D., M.S., to the Position of President - marketscreener.com

Mar 17, 2026
pulisher
Mar 17, 2026

Aug Movers: Should you avoid Personalis Inc stock right now2026 Price Momentum & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

Personalis Q2 2025 Earnings Preview - MSN

Mar 17, 2026
pulisher
Mar 13, 2026

Personalis (NASDAQ:PSNL) Trading 6.6% HigherTime to Buy? - MarketBeat

Mar 13, 2026
pulisher
Mar 12, 2026

Personalis (NASDAQ:PSNL) Stock Price Down 8.1%What's Next? - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal - BioSpace

Mar 12, 2026
pulisher
Mar 12, 2026

Personalis (PSNL) Publishes Promising Study on Cancer Detection Method - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® - Business Wire

Mar 12, 2026
pulisher
Mar 11, 2026

Personalis, Inc. (NASDAQ:PSNL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 11, 2026
pulisher
Mar 10, 2026

Growth Report: Is Personalis Inc showing insider buyingEarnings Growth Report & Consistent Profit Trade Alerts - baoquankhu1.vn

Mar 10, 2026
pulisher
Mar 08, 2026

Personalis (NASDAQ:PSNL) Rating Increased to Hold at Wall Street Zen - MarketBeat

Mar 08, 2026
pulisher
Mar 06, 2026

Momentum Shift: Is Personalis Inc benefiting from interest rate changesJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Is Personalis Inc. stock attractive after correctionTrade Risk Summary & Weekly High Momentum Picks - Naître et grandir

Mar 06, 2026
pulisher
Mar 06, 2026

Personalis Stock Pre-Market (-5.3%): FY26 Guidance Overshadows Q4 EPS Beat - Trefis

Mar 06, 2026
pulisher
Mar 05, 2026

Morgan Stanley Has Lowered Expectations for Personalis (NASDAQ:PSNL) Stock Price - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

PSNL: Morgan Stanley Maintains Equal-Weight, Lowers Price Target - GuruFocus

Mar 05, 2026
pulisher
Mar 05, 2026

Personalis, Inc. $PSNL Stake Boosted by ARK Investment Management LLC - MarketBeat

Mar 05, 2026
pulisher
Mar 04, 2026

Personalis, Inc. (NASDAQ:PSNL) Short Interest Up 21.2% in February - MarketBeat

Mar 04, 2026
pulisher
Mar 02, 2026

Personalis (NASDAQ:PSNL) Shares Gap DownTime to Sell? - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

Will Personalis Inc. outperform small cap indexesBear Alert & Free Verified High Yield Trade Plans - mfd.ru

Mar 01, 2026
pulisher
Feb 28, 2026

Breaking Down Personalis: 5 Analysts Share Their Views - Sahm

Feb 28, 2026
pulisher
Feb 28, 2026

Personalis, Inc. (NASDAQ:PSNL) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 28, 2026
pulisher
Feb 28, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (ACLX), DENTSPLY SIRONA (XRAY) and Personalis (PSNL) - The Globe and Mail

Feb 28, 2026
pulisher
Feb 28, 2026

Personalis (NASDAQ:PSNL) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat

Feb 28, 2026
pulisher
Feb 27, 2026

Personalis 2025 Financial Results: Revenue, Loss, and 2026 ForecastNews and Statistics - IndexBox

Feb 27, 2026
pulisher
Feb 27, 2026

Personalis, Inc. (PSNL) Stock Analysis: Exploring a Promising 24.98% Upside with Innovative Cancer Genomics - DirectorsTalk Interviews

Feb 27, 2026
pulisher
Feb 27, 2026

Personalis (NASDAQ:PSNL) Price Target Raised to $12.00 at Needham & Company LLC - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Personalis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 27, 2026
pulisher
Feb 27, 2026

Needham raises Personalis stock price target on reimbursement wins By Investing.com - Investing.com Nigeria

Feb 27, 2026
pulisher
Feb 27, 2026

Needham raises Personalis stock price target on reimbursement wins - Investing.com Australia

Feb 27, 2026
pulisher
Feb 27, 2026

PSNL Stock Sees Price Target Increase by Needham | PSNL Stock Ne - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

Personalis stock price target reaffirmed at $13 by BTIG on MRD growth - Investing.com South Africa

Feb 27, 2026
pulisher
Feb 27, 2026

Personalis Q4 Earnings Call Highlights - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Personalis Inc (PSNL) Q4 2025 Earnings Call Highlights: Robust C - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights - BioSpace

Feb 27, 2026
diagnostics_research DGX
$194.16
price down icon 0.55%
diagnostics_research LH
$264.09
price down icon 0.66%
diagnostics_research MTD
$1,190.49
price down icon 0.09%
diagnostics_research IQV
$166.47
price down icon 0.33%
$202.73
price up icon 2.50%
diagnostics_research WAT
$299.57
price up icon 1.53%
자본화:     |  볼륨(24시간):